Brain Imaging
Rationale and common goals
Brain imaging aims to provide an excellent research infrastructure by optimizing the available scanners and analysis platforms, that are both demand-driven and top-down, also for shared presentation to industry. This includes a full integration of research and teaching facilities, by construction of a cross-departmental interactive platform of Principal Investigators, cross-fertilization at the level of graduate training, shared fund-raising and resource utilization, and setting up a common imaging databanks and computing facilities.
Assets: high end infrastructure
The brain-imaging program has an extensive infrastructure including all available imaging modalities for magnetic resonance imaging (including 7T MRI as part of the Spinoza Center in Amsterdam), nuclear imaging techniques (including PET/MRI at VUmc campus), and magneto-electro-encephalography (MEG at the VUmc campus). This high end infrastructure comes with advanced expertise to support data acquisition, data management, development of advanced data and statistical analysis tools, and ultimately the incorporation of these advanced technologies into translation (e.g., through Institute Quantivision, and EATRIS). We provide services to other fields of medicine too, but the brain remains the main focus, at least for modalities such as MEG and high-field MRI.
Profiling
Improved profiling in human brain studies is provided by [a] fully translational brain imaging capacities (enhance weak points like micro PET/SPECT/MRI) from bench to bedside; [b] multi-modal imaging capacities (improve new technologies: high-field MRI, PET-MRI, OCT, in addition to experimental modulations such as DBS, rTMS, ECT, MRS, TDCS, realtime fMRI/EEG and improve close integration with physics and mathematics for receptor mapping, pharmaco-fMRI and network analysis); [c] minimally invasive programs suitable for ‘personalized medicine’ and drug-targeting strategies (focus on network analysis, defining new physiological parameters such as pharmaco-fMRI and other inventive receptor imaging strategies, neurofeedback, real time fMRI/EEG).
Making the difference
Brain imaging wishes to leverage the fully translational brain-imaging program, which focuses on multi-modal imaging and minimally invasive brain imaging techniques suitable for drug targeting strategies and individualization of treatment strategies. This is the available expertise of participating PIs and how we can make a difference compared to other large, more technology driven brain imaging facilities worldwide.
Program leaders
Taskforce team
Program members
-
A.J. Timmerman
-
Adriaan Lammertsma PROF.DR., (Principal Investigator)
-
Agnetha E. Bruggeman MD
-
Alex Poot DR.
-
Alle Meije Wink DR.IR.
-
Anouk L. van der Straten
-
Antonia Kaiser MSc
-
Arjan Hillebrand DR.IR.
-
Arnolt-Jan W. Hoving MD
-
Arthur-Ervin Avramiea
-
Bart van Berckel PROF.DR., (Principal Investigator)
-
Bert Windhorst PROF.DR., (Principal Investigator)
-
Betty Tijms DR., (Principal Investigator)
-
Carmen P. S. Blanken
-
Cheima Bouziane
-
Chris Vriend PhD, (Principal Investigator)
-
Cornelis Stam PROF.DR., (Principal Investigator)
-
D. Iannuzzi
-
Dennis van t Ent
-
Dilan D. Le Duc-Yucel MSc
-
Dirk Veltman PROF.DR., (Principal Investigator)
-
Dominique S. Scheepens MD
-
Egill A. Fridgeirsson
-
Elleke Tissink MSc
-
Elsmarieke M. van de Giessen
-
Erik M. Akkerman PhD
-
Eva S. Peper
-
Fiona Heeman MSC.
-
Fleur F. van Rootselaar PhD, (Principal Investigator)
-
Frederik Barkhof PROF.DR., (Principal Investigator)
-
Guido A. van Wingen PhD, (Principal Investigator)
-
H Marquering PhD, (Principal Investigator)
-
Hayel Tuncel
-
Henk van Voorst MSc
-
Henrica de Bie DR.
-
Hugo Vrenken DR.IR., (Principal Investigator)
-
Iman Brouwer IR.
-
Isadora Lopes Alves BSc.
-
Ivana Isgum , (Principal Investigator)
-
Jan Booij PhD, (Principal Investigator)
-
Jari Gool
-
Jithsa R. C. Monte
-
Johanna E. Hakonen
-
Johannes de Boer PROF.DR., (Principal Investigator)
-
Joost Kuijer DR.
-
Keith Cover
-
Klaus Linkenkaer Hansen
-
Leah S. Wilk MSc
-
Liesbeth Reneman Prof., (Principal Investigator)
-
Linda Douw DR., (Principal Investigator)
-
Loek P. Smits
-
Lucas A. Ramos
-
Luka C. Liebrand MSc
-
Lukas M. Gottwald
-
Maik Derksen
-
Manon L. Tolhuisen MSc
-
Maqsood Yaqub DR.IR.
-
Marc Huisman DR.IR.
-
Margo Slomp MSc
-
Mariah R. R. Daal
-
Marieke van der Pluijm
-
Mark BM Hofman DR.
-
Marthe Ford
-
Martine M. A. C. van Doorn MD
-
Matthan W. A. Caan PhD
-
Maurice C. G. Aalders PhD, (Principal Investigator)
-
MCM de Gunst
-
Menno Schoonheim DR., (Principal Investigator)
-
Michelle Nagtegaal
-
Michiel B. de Ruiter PhD
-
Miou S. Koopman
-
ML Groot
-
Myrle M. Stouten-Kemperman MSc
-
Myrtille C. R. Gumbs MSc
-
Nadine A. F. Eijsker
-
Niels de Joode
-
Nihad Achetib
-
Nina Levar MSc
-
Nora Runia MSc
-
Obada Al-Zghool
-
Paul Zhutovsky
-
Petra Pouwels DR., (Principal Investigator)
-
Praneeta R. Konduri
-
Richelle J. M. Hoveling
-
Ronald Boellaard PROF.DR., (Principal Investigator)
-
Rozemarijn Mattiesing
-
Sandeep Golla DR.
-
Sarvi Sharifi
-
Simon Houtman
-
SM Witte
-
Spela Korat
-
Stevie Tan PROF.DR., (Principal Investigator)
-
Sven R. Suwijn
-
Sybren de Kloet
-
Thomas Wünsche
-
Tom Bresser
-
Vera Keil DR.
-
Wieke A. van Leeuwen
-
Willem B. Bruin
-
Zhiqing Zhang